Positive crosstalk between EGFR and the TF-PAR2 pathway mediates resistance to cisplatin and poor survival in cervical cancer-Reference-Cited by-同舟云学术

Positive crosstalk between EGFR and the TF-PAR2 pathway mediates resistance to cisplatin and poor survival in cervical cancer

Published:2018-07-17 Issue:55 Volume:9 Page:30594-30609
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Hugo de Almeida Vitor¹²,Guimarães Isabella dos Santos²,Almendra Lucas R.¹,Rondon Araci M.R.¹,Tilli Tatiana M.³,de Melo Andréia C.²,Sternberg Cinthya²⁴,Monteiro Robson Q.¹

Affiliation:

1. Instituto de Bioquímica Médica Leopoldo De Meis, Universidade Federal do Rio de Janeiro, Rio de Janeiro, RJ, Brazil

2. Divisão de Pesquisa Clínica e Desenvolvimento Tecnológico, Instituto Nacional de Câncer, Rio de Janeiro, RJ, Brazil

3. Centro de Desenvolvimento Tecnológico em Saúde, Fundação Oswaldo Cruz, Rio de Janeiro, RJ, Brazil

4. Present address: Sociedade Brasileira de Oncologia Clínica (SBOC), Belo Horizonte, MG, Brazil

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 36 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. 1-palmitoyl-2-linoleoyl-3-acetyl-rac-glycerol treatment inhibits abnormal tumor growth by regulating neutrophil infiltration in a non-small cell lung carcinoma mouse model;Biomedicine & Pharmacotherapy;2024-09

2. Selective but not pan-CDK inhibition abrogates 5-FU-driven tissue factor upregulation in colon cancer;Scientific Reports;2024-05-08

3. Cancer Mutations Converge on a Collection of Protein Assemblies to Predict Resistance to Replication Stress;Cancer Discovery;2024-02-16

4. Mechanisms of chemotherapy resistance in cervical cancer;Strategies for Overcoming Chemotherapy Resistance in Cervical Cancer;2024

5. Proteinase-activated Receptor 2: Springboard of Tumors;Anticancer Research;2023-12-30